General information about company

Name of The CompanyANG Lifesciences India Limited
BSE Scrip Code540694
NSE Symbol
MSE Symbol
Date of Start of Financial Year01-04-2023
Date of End of Financial Year31-03-2024
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2023
Date of End of Reporting Period30-09-2023
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1ANG Lifesciences India LimitedAAHCA5390HRajesh GuptaAAQPG4797CPromoter & Managing DirectorRemunerationAs approved by Audit committee54-14.66-9.43Textual Information(1)
2ANG Lifesciences India LimitedAAHCA5390HRajesh GuptaAAQPG4797CPromoter & Managing DirectorAny other transactionRent paidAs approved by Audit committee1.5-1.40Textual Information(2)
3ANG Lifesciences India LimitedAAHCA5390HSaruchi gupta ALAPG5323RPromoter & Managing DirectorRemunerationAs approved by Audit committee27-8.69-1.15Textual Information(3)
4ANG Lifesciences India LimitedAAHCA5390HSudesh KumariALAPG5323RNon executive non independent directorAny other transactionSitting feesAs approved by Audit committee0.3500Textual Information(4)
5ANG Lifesciences India LimitedAAHCA5390HPawanjit Singh ACUPS4040CNon executive independent directorAny other transactionSitting feesAs approved by Audit committee0.1500Textual Information(5)
6ANG Lifesciences India LimitedAAHCA5390HSukhpal SinghABMPS4053NNon executive independent directorAny other transactionSitting feesAs approved by Audit committee0.300Textual Information(6)
7ANG Lifesciences India LimitedAAHCA5390HChetna AVEPC8499ANon executive independent directorAny other transactionSitting feesAs approved by Audit committee0.35-0.150Textual Information(7)
8ANG Lifesciences India LimitedAAHCA5390HRenu KaurCJIPK0609NCompany SecretaryRemunerationAs approved by Audit committee2.8-0.77-52Textual Information(8)
9ANG Lifesciences India LimitedAAHCA5390HRenatus Meditech Solution Pvt Ltd AAKCR1772RCompany's Promoter Mr. Rajesh Gupta holds shareholdingAdvanceAs approved by Audit committee2.82100.887.37Textual Information(9)
10ANG Lifesciences India LimitedAAHCA5390HRenatus Meditech Solution Pvt Ltd AAKCR1772RCompany's Promoter Mr. Rajesh Gupta holds shareholdingAny other transactionAdvance taken backAs approved by Audit committee16.2500Textual Information(10)
11ANG Lifesciences India LimitedAAHCA5390HBaddi Agro Pvt Ltd AAJCB7928ECompany's Promoter Significant InfluenceAdvanceAs approved by Audit committee01432.781432.78Textual Information(11)
12ANG Lifesciences India LimitedAAHCA5390HBaddi Agro Pvt Ltd AAJCB7928ECompany's Promoter Significant InfluenceAny other transactionAdvance taken backAs approved by Audit committee000Textual Information(12)
13ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluenceSale of goods or servicesAs approved by Audit committee89.9300Textual Information(13)
14ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluencePurchase of goods or servicesAs approved by Audit committee304.95-450.57-428.12Textual Information(14)
15ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluenceAny other transactionInterest Received As approved by Audit committee9.23204.1212.41Textual Information(15)
16ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluenceAny other transactionTDS Received As approved by Audit committee0.9200Textual Information(16)
17ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluenceAny other transactionCommission As approved by Audit committee7.123.39.74Textual Information(17)
18ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers Ltd AADCM9521ECompany's Promoter Significant InfluenceAny other transactionGuarantee As approved by Audit committee0.6900Textual Information(18)
19ANG Lifesciences India LimitedAAHCA5390HANG Capital Investments Pvt LtdAAWCA6542JCompany's Promoter Significant InfluenceAdvanceAs approved by Audit committee10.7010.7Textual Information(19)
20ANG Lifesciences India LimitedAAHCA5390HANG Capital Investments Pvt LtdAAWCA6542JCompany's Promoter Significant InfluenceAny other transactionAdvance taken backAs approved by Audit committee000Textual Information(20)
21ANG Lifesciences India LimitedAAHCA5390HANG Energy Limited AAVCA9883FCompany's Promoter Significant InfluenceAdvanceAs approved by Audit committee0.900.4Textual Information(21)
22ANG Lifesciences India LimitedAAHCA5390HANG Energy Limited AAVCA9883FCompany's Promoter Significant InfluenceAny other transactionAdvance taken backAs approved by Audit committee0.500Textual Information(22)
23ANG Lifesciences India LimitedAAHCA5390HANG Energy Limited AAVCA9883FCompany's Promoter Significant InfluenceAny other transactionUnsecured Loan As approved by Audit committee0.300Textual Information(23)
24ANG Lifesciences India LimitedAAHCA5390HANG Energy Limited AAVCA9883FCompany's Promoter Significant InfluenceAny other transactionUnsecured Loan given backAs approved by Audit committee0.300Textual Information(24)
25ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluencePurchase of goods or servicesAs approved by Audit committee525.38036.33Textual Information(25)
26ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluenceSale of goods or servicesAs approved by Audit committee0.1700Textual Information(26)
27ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluenceAny other transactionUnsecured Loan As approved by Audit committee33-15.020Textual Information(27)
28ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluenceAny other transactionUnsecured Loan paidAs approved by Audit committee48.0200Textual Information(28)
29ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluenceAdvanceAs approved by Audit committee32.9200Textual Information(29)
30ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's Promoter Significant InfluenceAny other transactionAdvance taken backAs approved by Audit committee32.9200Textual Information(30)
31ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt LtdAAOCA3292RCompany's Promoter Significant InfluenceSale of goods or servicesAs approved by Audit committee721.81304.791978.77Textual Information(31)
32ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt LtdAAOCA3292RCompany's Promoter Significant InfluenceAny other transactionAdvance taken backAs approved by Audit committee456.300Textual Information(32)
33ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt LtdAAOCA3292RCompany's Promoter Significant InfluenceInterest receivedAs approved by Audit committee5.2-84.61-89.82Textual Information(33)
34ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt LtdAAOCA3292RCompany's Promoter Significant InfluencePurchase of goods or servicesAs approved by Audit committee0.4600Textual Information(34)
Total value of transaction during the reporting period2387.23